Reply to comment on: Strong reduction of AGO2 expression in melanoma and cellular consequences.
作者信息
Völler D, Bosserhoff A
机构信息
Institute of Pathology, University of Regensburg, Franz-Josef Strauss Allee 11, 93053 Regensburg, Germany.
出版信息
Br J Cancer. 2014 Oct 14;111(8):1673. doi: 10.1038/bjc.2014.57. Epub 2014 Feb 20.
Abstract
摘要
相似文献
1
Reply to comment on: Strong reduction of AGO2 expression in melanoma and cellular consequences.
Br J Cancer. 2014 Oct 14;111(8):1673. doi: 10.1038/bjc.2014.57. Epub 2014 Feb 20.
2
Comment on 'Strong reduction of AGO2 expression in melanoma and cellular consequences'.
Br J Cancer. 2014 Oct 14;111(8):1673. doi: 10.1038/bjc.2014.56. Epub 2014 Feb 20.
3
Strong reduction of AGO2 expression in melanoma and cellular consequences.
Br J Cancer. 2013 Dec 10;109(12):3116-24. doi: 10.1038/bjc.2013.646. Epub 2013 Oct 29.
4
Quantitative functions of Argonaute proteins in mammalian development.
Genes Dev. 2012 Apr 1;26(7):693-704. doi: 10.1101/gad.182758.111.
5
Argonaute 2 Is Required for Extra-embryonic Endoderm Differentiation of Mouse Embryonic Stem Cells.
Stem Cell Reports. 2018 Feb 13;10(2):461-476. doi: 10.1016/j.stemcr.2017.12.023. Epub 2018 Jan 26.
6
miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy.
J Biol Chem. 2015 Dec 18;290(51):30342-50. doi: 10.1074/jbc.M115.691857. Epub 2015 Oct 30.
7
Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.01297-18. Print 2019 Feb 1.
8
Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells.
Cell Death Dis. 2019 Jan 8;10(1):17. doi: 10.1038/s41419-018-1267-5.
9
siRNA enrichment in Argonaute 2-depleted Blattella germanica.
Biochim Biophys Acta Gene Regul Mech. 2021 Jun-Jul;1864(6-7):194704. doi: 10.1016/j.bbagrm.2021.194704. Epub 2021 Apr 22.
10
Akt-mediated phosphorylation of argonaute 2 downregulates cleavage and upregulates translational repression of MicroRNA targets.
Mol Cell. 2013 May 9;50(3):356-67. doi: 10.1016/j.molcel.2013.03.015. Epub 2013 Apr 18.
本文引用的文献
1
Strong reduction of AGO2 expression in melanoma and cellular consequences.
Br J Cancer. 2013 Dec 10;109(12):3116-24. doi: 10.1038/bjc.2013.646. Epub 2013 Oct 29.
2
Expression levels of microRNA machinery components Drosha, Dicer and DGCR8 in human (AGS, HepG2, and KEYSE-30) cancer cell lines.
Int J Clin Exp Med. 2013 Apr 12;6(4):269-74. Print 2013.
3
Expression of the RNase III enzyme DROSHA is reduced during progression of human cutaneous melanoma.
Mod Pathol. 2013 Jul;26(7):902-10. doi: 10.1038/modpathol.2012.225. Epub 2013 Feb 1.
4
MicroRNAs in malignant melanoma.
Clin Biochem. 2013 Jul;46(10-11):909-17. doi: 10.1016/j.clinbiochem.2013.01.008. Epub 2013 Jan 27.
5
Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells.
Neoplasia. 2012 Mar;14(3):238-48. doi: 10.1593/neo.111586.
6
Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer.
Mol Carcinog. 2012 Nov;51(11):916-22. doi: 10.1002/mc.20861. Epub 2011 Oct 24.
7
Up-regulated Dicer expression in patients with cutaneous melanoma.
PLoS One. 2011;6(6):e20494. doi: 10.1371/journal.pone.0020494. Epub 2011 Jun 17.
Zotero 插件